Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 204,595 | 102,192 | 184,201 | 112,724 | 96,648 |
| Marketable Securities | 245,095 | 286,540 | 233,627 | 289,113 | 284,495 |
| Receivables | 98,309 | 117,207 | 87,109 | 74,336 | 60,240 |
| Inventories | 4,377 | 4,572 | 4,372 | 3,836 | 3,873 |
| TOTAL | $561,989 | $537,229 | $522,782 | $501,704 | $474,429 |
| Non-Current Assets | |||||
| PPE Net | 20,489 | 17,672 | 11,665 | 5,746 | 3,182 |
| Investments And Advances | 6,682 | 3,870 | 3,870 | 3,000 | 3,000 |
| Intangibles | 6,885 | 7,126 | 7,366 | 7,606 | 7,846 |
| Other Non-Current Assets | 15,097 | 15,238 | 16,475 | 16,505 | 6,537 |
| TOTAL | $49,153 | $43,906 | $39,376 | $32,857 | $20,565 |
| Total Assets | $611,142 | $581,135 | $562,158 | $534,561 | $494,994 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 40,141 | 24,131 | 16,387 | 103,498 | 78,641 |
| TOTAL | $175,753 | $143,508 | $135,695 | $117,050 | $90,253 |
| Non-Current Liabilities | |||||
| Long Term Debt | 72,762 | 72,597 | 72,438 | 72,281 | 72,129 |
| Other Non-Current Liabilities | 15,895 | 16,079 | 10,599 | 10,148 | 0 |
| TOTAL | $88,657 | $88,676 | $83,037 | $82,429 | $72,129 |
| Total Liabilities | $264,410 | $232,184 | $218,732 | $199,479 | $162,382 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,883 | 43,024 | 42,557 | 42,449 | 42,214 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -452,146 | -433,595 | -426,628 | -418,255 | -405,670 |
| Other shareholders' equity | -557 | -298 | 381 | 289 | 39 |
| TOTAL | $346,732 | $348,951 | $343,426 | $335,082 | $332,612 |
| Total Liabilities And Equity | $611,142 | $581,135 | $562,158 | $534,561 | $494,994 |